CJC-1295 5 mg vial
- Panda Peptides$24.49Listed priceCOA tested Sep 16, 2026
- Bulk Peptide Supply$30Listed price · deal not verifiedCOA tested May 20, 2026
- Ameano Peptides$38Listed priceCOA tested Jun 8, 2026
CJC-1295 is a synthetic, long-acting analog of growth-hormone-releasing hormone designed to extend signaling compared with native GHRH.
Also known as cjc 1295 · cjc-1295 · cjc1295
Current picks · Nov 14, 2026
Up to three of the lowest effective prices per exact product among vendors that passed the trust floor, were in stock and checked within 72 hours, and have a COA on file for that product and strength tested within 12 months. Affiliate relationships never affect picks or their order.
Same format. Same amount.
2 of 4 exact products have at least one pick. Vendor counts reflect the current price observations. Testing records for every vendor and strength: CJC-1295 COAs →
Historical market context
Historical market low and median per mg across recorded offers. These market summaries are separate from our exact-product comparisons.
History updated Sep 21, 2026. Vendor coverage, package sizes, product forms and promotions can vary over time. Use exact-product comparisons for current listed prices; historical market prices do not establish vendor trust.
| Date | Low /mg | Median /mg | Vendors | Offers |
|---|---|---|---|---|
| $6.38 | $12.50 | 2 | 4 | |
| $6.00 | $10.55 | 3 | 8 |
What it is
PubChem describes CJC-1295 as a maleimide derivative of hGRF(1–29). Catalogs may use the CJC-1295 name for variants with different conjugation or duration, so the exact molecule matters.
This label describes the available research record, not whether the compound is safe or effective for an individual.
Research context
Indexed human research reports prolonged growth-hormone and IGF-1 secretion, and a registered study examined HIV-associated visceral obesity. Hormone changes are not the same as proven clinical benefit, and variant naming limits broad comparisons.
Search indexed research for this compound ↗Market context
CJC-1295 is commonly sold or discussed for growth hormone signaling, recovery, body composition, and performance research. That describes market demand, not proof that the compound is safe or effective.
Market demand and online discussion do not establish product quality, safety, or effectiveness.Vendor directory
Grades describe the vendor record overall, not a test of every product. Lowest prices are effective single-package prices across formats; open a comparison for the exact product.
| Vendor | Grade | Offers | In stock | Lowest effective package |
|---|---|---|---|---|
| Amino Science | Grade A- | 2 | 2 | $53.99 · 2 mg vialObserved Nov 14, 2026 |
| EZ Peptides | Grade A- | 1 | 1 | $38 · 5 mg vialObserved Nov 14, 2026 |
| Nura Peptide | Grade A- | 1 | 1 | $45 · 5 mg vialEarlier observation Oct 9, 2026 |
| Polaris Peptides | Grade A- | 1 | 1 | $60 · 10 mg vialObserved Nov 14, 2026 |
| Ascension Peptides | Grade A- | 2 | 2 | $45 · 5 mg vialObserved Nov 14, 2026 |
| Evolve Peptides | Grade A- | 2 | 2 | $40.90 · 5 mg vialObserved Nov 14, 2026 |
| GenPeptide | Grade A- | 1 | 1 | $35 · 5 mg vialEarlier observation Oct 20, 2026 |
| Puratek Peptides | Grade A- | 1 | 1 | $44.95 · 10 mg vialObserved Nov 14, 2026 |
| Southern Aminos | Grade A- | 1 | 1 | $44 · 10 mg vialEarlier observation Nov 2, 2026 |
| Bulk Peptide Supply | Grade B+ | 3 | 3 | $25 · 10 mg vialObserved Nov 14, 2026 |
| Ameano Peptides | Grade B+ | 1 | 1 | $38 · 5 mg vialObserved Nov 14, 2026 |
| Blue Ridge Peptides | Grade B+ | 1 | 1 | $60 · 10 mg vialObserved Nov 14, 2026 |
| Glacier Aminos | Grade B+ | 2 | 2 | $51.99 · 5 mg vialObserved Nov 14, 2026 |
| Panda Peptides | Grade B+ | 1 | 1 | $24.49 · 5 mg vialObserved Nov 14, 2026 |
| Alpha Peps | Grade B+ | 1 | 1 | $90 · 10 mg vialObserved Nov 14, 2026 |
| Alpha Pro Peptides | Grade B+ | 2 | 2 | $32.50 · 2 mg vialObserved Nov 14, 2026 |
| Peptide Crafters | Grade B+ | 1 | 1 | $30 · 5 mg vialEarlier observation Nov 1, 2026 |
| Oasis Peptides | Grade B+ | 1 | 1 | $39 · 5 mg vialObserved Nov 14, 2026 |
| Oros Research | Grade B+ | 1 | 1 | $24.99 · 5 mg vialEarlier observation Oct 29, 2026 |
| Silverstone Labs | Grade B+ | 1 | 1 | $34 · 10 mg vialObserved Nov 14, 2026 |
| Core Peptides | Grade B+ | 1 | 1 | $41 · 5 mg vialEarlier observation Oct 20, 2026 |
| Ignite Peptides | Grade B | 1 | 1 | $25 · 10 mg vialObserved Nov 14, 2026 |
| Simple Peptide | Grade B | 2 | 2 | $35 · 5 mg vialEarlier observation Sep 27, 2026 |
| Paramount Peptides | Grade B | 1 | 1 | $65.45 · 10 mg vialObserved Nov 14, 2026 |
| NuLife Peptides | Grade B | 1 | 1 | $42.50 · 5 mg vialEarlier observation Oct 17, 2026 |
| NextechLabs | Grade C | 1 | 1 | $52.50 · 5 mg vialEarlier observation Oct 4, 2026 |
| Nova Life Peptides | Not graded | 1 | 1 | $60 · 5 mg vialObserved Nov 14, 2026 |
| Nuscience Peptides | Not graded | 1 | 1 | $54.99 · 5 mg vialObserved Nov 14, 2026 |
| Peptides 4 Research | Not graded | 1 | 1 | $34 · 5 mg vialObserved Nov 14, 2026 |
| Pharma Grade Peptides | Not graded | 1 | 1 | $84.99 · 10 mg vialObserved Nov 14, 2026 |
| Skye Peptides | Not graded | 1 | 1 | $69 · 10 mg vialObserved Nov 14, 2026 |
| Tydes | Not graded | 1 | 1 | $69.99 · 10 mg vialObserved Nov 14, 2026 |
23 tracked vendors list CJC-1295 without a current offer: Peptide Partners (Grade B+), Licensed Peptides (Grade B+), RIVN Peptides (Grade B+), SaiyanMed (Grade B+), TCore Biotech (Grade B), Biolongevity Labs (Grade B), Ion Peptides (Grade B), RUO (Grade B), Chameleon Peptides (Grade B), Nation Peptides (Grade B), Nationwide Peptides (Grade B+), VAYN (Grade B), Blank Peptides (Grade B), Royal Peptides (Grade B), Vital Core Research (Grade B), Mile High Compounds (Grade B), Peptidology (Grade C), Oath Research (Grade C), Swiss Chems (Grade C), American Peptide Research (Not graded), Atomik Labz (Not graded), Longevity Peptides (Not graded), Northline Labs (Not graded).
Sources and review
Last editorial review: Aug 30, 2026. Sources support the compound guide only and do not affect vendor grades.